Hikma Pharmaceuticals (GB:HIK) has released an update.
Hikma Pharmaceuticals is set to reveal its interim financial results for the first half of 2024 on August 8th, with a presentation and a live Q&A session for analysts to follow. Interested parties can access a recording of the presentation and the Q&A on the company’s website, ensuring stakeholders are well-informed about Hikma’s recent financial performance.
For further insights into GB:HIK stock, check out TipRanks’ Stock Analysis page.
